Singapore minister clarifies Allianz-Income deal halt following “misperceptions” on government’s role
November 7 2024 by Joana Nguyen
-
Howden expands in Hong Kong with Storfield acquisition
- November 12
The SAR-based broker has a specialist focus on bloodstock, fine art, luxury vehicle and yacht insurance.
-
Steadfast expands into London market with US$30m Lloyd’s broker HW Wood buy
- November 7
The acquisition, which is expected to be completed on December 2, gives the Australian group full ownership of the target, including its operations in France and Greece.
-
Steadfast on track to complete US$200m in acquisitions in FY 2025
- November 4
In its annual general meeting, the Australian broking group addressed allegations of opacity in its strata operations and leadership succession.
-
QBE closes US$1.6bn LPT deal with RiverStone International and Enstar
- November 1
The deal was effective July 1 this year and includes non-core long-tail reserves that were not subject to prior reinsurance transactions and a small number of other portfolios of various subsidiaries of the insurer, including Lloyd’s syndicates.
-
BHSI | Managing non-Asian exposure in long-tail lines
While US-exposed business can look attractive to Asian carriers, managing the volatility around the long-term results and the ability to model those losses are crucial, say BHSI’s Marc Breuil and Marcus Portbury.
-
Sedgwick | To Handle CAT Claims Well, Multi-Step Preparation is Key
When it comes to risk, it’s not a matter of “if” it’s a matter of “when” an event will occur.
-
HSBC Asset Management | Is it time to relook at Asian currency bonds?
With diversification and performance high on investors’ agendas, it seems a good time for global portfolios to revive allocations in Asian local currency bonds – including Hong Kong dollar (HKD) bonds.
-
PineBridge Investments | Why Asian insurers are exploring private credit and CLOs
The recent rollout of risk-based capital regimes across Asia calls for a closer alignment between insurers’ assets and liabilities. We explore potential ways to maintain a healthy investment yield and robust returns on regulatory capital.
